Insulin Detemir Injection Shortage
Last Updated: January 13, 2025
Status: Current
Products Affected - Description
-
- Levemir subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL vial, 1 count, NDC 00169-3687-12 - discontinued
- Levemir Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-6432-10 - discontinued
Reason for the Shortage
-
- NovoNordisk transitioned Levemir injection out of the US market at the end of 2024. The vials and FlexPens have both been discontinued.
Available Products
-
- There are no presentations available
Updated
Updated January 13, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 13, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.